Literature DB >> 21864490

Nanoparticle augmented radiation treatment decreases cancer cell proliferation.

Helen E Townley1, Elizabeth Rapa, Gareth Wakefield, Peter J Dobson.   

Abstract

We report significant and controlled cell death using novel x-ray-activatable titania nanoparticles (NPs) doped with lanthanides. Preferential incorporation of such materials into tumor tissue can enhance the effect of radiation therapy. Herein, the incorporation of gadolinium into the NPs is designed to optimize localized energy absorption from a conventional medical x-ray. This result is further optimized by the addition of other rare earth elements. Upon irradiation, energy is transferred to the titania crystal structure, resulting in the generation of reactive oxygen species (ROS). FROM THE CLINICAL EDITOR: The authors report significant and controlled cell death using x-ray-activated titania nanoparticles doped with lanthanides as enhancers. Upon irradiation X-ray energy is transferred to the titania crystal structure, resulting in the generation of reactive oxygen species.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21864490     DOI: 10.1016/j.nano.2011.08.003

Source DB:  PubMed          Journal:  Nanomedicine        ISSN: 1549-9634            Impact factor:   5.307


  10 in total

1.  In vivo demonstration of enhanced radiotherapy using rare earth doped titania nanoparticles.

Authors:  Helen E Townley; Jeewon Kim; Peter J Dobson
Journal:  Nanoscale       Date:  2012-07-06       Impact factor: 7.790

2.  Enhanced dose measurement of zinc oxide nanoparticles by radiochromic polymer dosimeter and Monte Carlo simulation.

Authors:  Nooshin Banaee
Journal:  Rep Pract Oncol Radiother       Date:  2020-04-27

Review 3.  Nanoparticles for Radiation Therapy Enhancement: the Key Parameters.

Authors:  Paul Retif; Sophie Pinel; Magali Toussaint; Céline Frochot; Rima Chouikrat; Thierry Bastogne; Muriel Barberi-Heyob
Journal:  Theranostics       Date:  2015-06-11       Impact factor: 11.556

4.  Reactive oxygen species generation in aqueous solutions containing GdVO4:Eu3+ nanoparticles and their complexes with methylene blue.

Authors:  Kateryna Hubenko; Svetlana Yefimova; Tatyana Tkacheva; Pavel Maksimchuk; Igor Borovoy; Vladimir Klochkov; Nataliya Kavok; Oleksander Opolonin; Yuri Malyukin
Journal:  Nanoscale Res Lett       Date:  2018-04-13       Impact factor: 4.703

Review 5.  Mechanisms for Tuning Engineered Nanomaterials to Enhance Radiation Therapy of Cancer.

Authors:  Sandhya Clement; Jared M Campbell; Wei Deng; Anna Guller; Saadia Nisar; Guozhen Liu; Brian C Wilson; Ewa M Goldys
Journal:  Adv Sci (Weinh)       Date:  2020-10-28       Impact factor: 16.806

Review 6.  Standards and Methodologies for Characterizing Radiobiological Impact of High-Z Nanoparticles.

Authors:  Anna Subiel; Reece Ashmore; Giuseppe Schettino
Journal:  Theranostics       Date:  2016-06-20       Impact factor: 11.556

7.  Photodynamic N-TiO2 Nanoparticle Treatment Induces Controlled ROS-mediated Autophagy and Terminal Differentiation of Leukemia Cells.

Authors:  Mohammad Amin Moosavi; Maryam Sharifi; Soroush Moasses Ghafary; Zahra Mohammadalipour; Alireza Khataee; Marveh Rahmati; Sadaf Hajjaran; Marek J Łos; Thomas Klonisch; Saeid Ghavami
Journal:  Sci Rep       Date:  2016-10-04       Impact factor: 4.379

8.  Efficacy of radiosensitizing doped titania nanoparticles under hypoxia and preparation of an embolic microparticle.

Authors:  Rachel A Morrison; Malgorzata J Rybak-Smith; James M Thompson; Bénédicte Thiebaut; Mark A Hill; Helen E Townley
Journal:  Int J Nanomedicine       Date:  2017-05-18

9.  Direct quantification of rare earth doped titania nanoparticles in individual human cells.

Authors:  J C G Jeynes; C Jeynes; V Palitsin; H E Townley
Journal:  Nanotechnology       Date:  2016-06-03       Impact factor: 3.874

10.  Enhancement of mitochondrial ROS accumulation and radiotherapeutic efficacy using a Gd-doped titania nanosensitizer.

Authors:  Yuanyuan Chen; Na Li; Jianbo Wang; Xia Zhang; Wei Pan; Longhai Yu; Bo Tang
Journal:  Theranostics       Date:  2019-01-01       Impact factor: 11.556

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.